Parkinson’s progression prediction using machine learning and serum cytokines

Increased levels of platelet-derived growth factor in LRRK2-PD serum. a Overview of patient sample numbers and data collection. Baseline platelet-derived growth factor b and monocyte chemoattractant protein 1 c levels in Parkinson’s disease patients with (red squares) and without (blue circles) the LRRK2 G2019S mutation. Data were compared using Student’s t test. Graphs show mean？±？SEM, n？=？80 per group. d Log2 changes over 1 year for all 27 cytokine measurements in all patients. N？=？16